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Abstract
Background: Mental health problems commonly begin in adolescence when the majority of people are living
with family. This can be a frightening time for relatives who often have little knowledge of what is happening or
how to manage it. The UK National Health Service has a commitment to support relatives in order to reduce their
distress, but research studies have shown that this can lead to a better outcome for service users as well.
Unfortunately, many relatives do not get the kind of support they need. We aim to evaluate the feasibility,
acceptability and effectiveness of providing and supporting a Relatives’ Education and Coping Toolkit (REACT) for
relatives of people with recent onset psychosis.
Methods: The study is a randomised control trial. Trial Registration for Current Controlled Trials ISRCTN69299093.
Relatives of people receiving treatment from the Early Intervention Service for psychosis are randomly allocated to
receive either Treatment As Usual (TAU) or TAU plus the REACT intervention. The main aims of the study are to:
(i) determine the acceptability of a supported self-management intervention; (ii) determine preference for type of
support; (iii) assess the feasibility of the design; (iv) identify the barriers and solutions to offering support for self-
management approaches within the NHS; (v) estimate the likely effect size of the impact of the intervention on
outcome for relatives; (vi) gain detailed feedback about the barriers and solutions to using a self-management
approach; (vii) describe the way in which the intervention is used. Outcomes will be assessed from baseline and at
6 month follow-up.
Discussion: The intervention is compared to current treatment in a sample of participants highly representative of
relatives in routine early intervention services across the UK. The intervention is protocolised, offered within routine
practice by existing staff and extensive process data is being collected. Randomisation is independent; all
assessments are made by blind raters. The limitations of the study are the lack of control over how the
intervention is delivered, the short follow-up period, and the lack of assessment of service user outcomes. Despite
these, the findings will inform future effectiveness trials and contribute to the growing evidence base for
supported self-mangement interventions in mental health.
* Correspondence: f.lobban@lancaster.ac.uk
1Spectrum Centre for Mental Health Research, School of Health and
Medicine, Lancaster University, Lancaster, LA1 4YT, UK
Full list of author information is available at the end of the article
Lobban et al. BMC Psychiatry 2011, 11:100
http://www.biomedcentral.com/1471-244X/11/100
© 2011 Lobban et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Background
Psychosis affects approximately 1% of people and is the
third most disabling condition worldwide [1]. First epi-
sode commonly occurs in adolescence at which time it
is estimated that 60-70% will be living with their family
[2]. The government recognises the very important role
of relatives and is committed to providing them with
appropriate support via NHS services [3]. Family inter-
ventions (FIs) are effective in improving outcome for
people with psychosis and their relatives. As an adjunct
to pharmacotherapy, FIs reduce relapse and hospitalisa-
tion rates [4,5]. FIs generally focus on cognitive and
behavioural techniques to modify appraisals that rela-
tives hold about the behaviour of the person with psy-
chosis and develop coping strategies. Research is limited
in its focus on people with more chronic mental health
difficulties, and lack of attention to outcomes for rela-
tives. However, interventions that are well integrated
into Early Intervention Services (EIS) show reductions
in relatives’ distress [6], and appraisals held by relatives
at first episode of psychosis are significant predictors of
important determinants of outcome [7].
Significant barriers still exist to the dissemination of
effective interventions through NHS EIS. These include
clinicians with high caseloads and lack of confidence
and training in working with relatives [8]. As a result,
relatives report significant negative impact on many
areas of their life, and the risk of distress is even higher
at first episode than at later stages [9].
There is a clear need for an intervention that can be
widely available to relatives, is easy to use, phase specific,
recovery focussed, does not require extensive clinical
resources, targets key appraisals and coping strategies
and empowers relatives. Self-management interventions
that have the flexibility to be used alongside other work
and family commitments and augment other forms of
support are ideally suited to meet the needs of relatives.
Self-management refers to health technologies (written/
audio/video/computer/internet) to assist users to manage
a particular health problem, with little or no professional
input. They can be used as stand-alone interventions or
as an adjunct to other forms of intervention. This is a
rapidly growing area and a recent meta-analysis of stu-
dies evaluating such approaches for depression shows
promising results [10]. Greater effectiveness is associated
with using a ‘guided’ model with low-level contact with a
professional/paraprofessional, and a CBT (Cognitive
Behaviour Therapy) rather than educational model [10].
Self-management approaches can increase dissemination
of evidence based interventions to large numbers of peo-
ple, and foster empowerment. Although much self-help
literature has been written for a wide range of mental
health problems, there is little development in the area of
psychosis and few high quality evaluations from which
conclusions can be drawn regarding effectiveness [11].
We are not aware of any studies which have systemati-
cally evaluated the use of a supported self-management
approach for relatives of people with psychosis.
This paper describes the rationale and protocol for a
randomised controlled trial in which relatives of people
at first episode psychosis in EIS receive current treatment
or current treatment plus the REACT supported self-
management toolkit. The main aims of the study are (i)
to determine the acceptability of a supported self-
management intervention and outcome measures to rela-
tives of people with recent onset psychosis; (ii) to deter-
mine preference for type of support (email/telephone);
(iii) to assess the feasibility of the design as measured by
rates of recruitment, retention, attendance and direct
feedback from participants; (iv) to identify the barriers
and solutions to offering support for self-management
approaches for relatives of people with psychosis in the
NHS; (v) to estimate the likely effect size of the impact of
the intervention on outcome for relatives; (vi) to gain
detailed feedback from relatives about the barriers and
solutions to using a self-management approach; (vii) to
describe the way in which the intervention is used. This
is not intended as a ‘definitive’ randomised controlled
trial and will not assess the impact on patient outcomes
or cost effectiveness. Further funding will be sought to
address these issues if this study supports the feasibility.
Methods
This trial is conducted by a multidisciplinary team of
researchers, clinicians, statistician and relatives based
across academic institutions and NHS Trusts in the
North West of England. The research team are respon-
sible for the content of the intervention and have
worked with a design company to produce the toolkit
and website. The trial is supported by an independent
Trial Steering Committee.
Design
Randomisation, Treatment Allocation and Blinding
This is a stratified randomised controlled trial in which
participants are allocated to receive either Treatment As
Usual (TAU) or TAU plus the REACT intervention. Ran-
domisation is done using permuted blocks within Trust
with block sizes varying randomly, and is carried out by
an independent Clinical Trials Unit at The Christie NHS
Foundation Trust, Manchester. Assessments are carried
out in face-to-face interviews at baseline and at 6 months
follow-up. Participants are referred into the study by
Care Coordinators or self-referral. Potential participants
are contacted by a research assistant (RA1) who presents
them with verbal and written information about the
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Page 2 of 7study. If they wish to take part, the participant is asked to
give written consent. Following this, a baseline interview
is conducted to assess eligibility and to complete all the
measures. A second research assistant (RA2) then con-
tacts the Clinical Trials Unit and provides information
about which Trust the relative is in. They are given the
trial allocation by telephone. RA2 contacts the relative by
telephone and post to inform them which arm of the trial
they have been allocated to. RA2 contacts the relevant
support worker who will guide the relative through the
intervention and instructs them to arrange the first
appointment with the participant. RA2 also arranges the
6 month follow-up interview date. In order to ensure that
outcomes are collected blind to the treatment allocation,
a letter is sent prior to this interview reminding the parti-
cipant about the importance of not letting RA1 know
which group they were allocated to, and making sure that
the REACT toolkit is not visible in the house. This is fol-
lowed-up with a phone call the day before the interview
to check the appointment time is convenient and to
reiterate the need to maintain blindness. RA1 conducts
all of the follow-up interviews and remains blind to allo-
cation throughout the study. To ensure blindness, all
communication between relatives and NHS staff is via
RA2. The RAs are housed in separate offices and receive
individual supervision. Any instances of unblinding will
be recorded.
This study was reviewed and approved by the UK
NHS Ethics Committee process (REC ref: 08/H1001/
147).
Qualitative evaluation
Qualitative interviews will be used to help us understand
how the intervention is used and experienced. Relatives
participating in the intervention arm of trial will form the
strategic sampling pool and will be invited to take part in
lightly structured interviews to explore key domains
around their use of and experience of the intervention,
focusing on the barriers to using the intervention and
potential solutions to overcome these. Recruitment will
continue until data saturation is reached (estimate
approx 10-15 relatives).
Participants
Inclusion criteria
Three NHS Mental Health Trusts in the North West UK
are taking part in this study. Each trust has an Early
Intervention Service for Psychosis team which supports
young adults who are experiencing symptoms of psycho-
sis for a period of up to 3 years. Participants are relatives,
partners or close friends of people currently receiving
support from one of these teams. Additional criteria
include: first contact with EIS within the last 24 months;
sufficient understanding of written and spoken English to
be able to use the intervention; aged over 18.
Recruitment and consent
Only relatives who already have direct contact with
each EIS, and for whom the service has current con-
tact details are invited to take part in the research.
This includes relatives currently on the “family and
friends group” lists, currently attending groups, and
currently receiving face-to-face input from clinical staff
and support workers. No relatives are contacted using
details taken from patient medical notes without
patient consent. No information is collected about the
service user. Therefore, service users will not be
required to consent into the study. However, to ensure
service users are aware of the study and could invite
any of their relatives not currently involved with the
service, each service will write to all service users
informing them about the study and send them a copy
of the relatives’ information sheet with a covering let-
ter asking them to pass this to any relatives that they
w o u l db eh a p p yf o ru st oi n v i t ea n dw h ot h e yf e e lm a y
be interested in taking part.
Care Coordinators will be informed about the study in
a series of presentations given by the research team.
They will be asked to discuss the study with relatives
they are working with and to refer any relatives inter-
ested in taking part who consent to their details being
given to the research team. A series of presentations will
also be made to relatives at any service user and care
events that happen in the Trusts during the recruitment
phase. These will encourage relatives to refer themselves
into the study if they wish to take part. A website will
also be set up that enables confidential referrals to be
made either by Care Coordinators or directly from
relatives.
Sample Size
The main aim of the study is to assess the feasibility of
the design and intervention. The sample required for
this is not based on a formal power calculation but on a
pragmatic decision balancing sufficient numbers to be
able to identify likely barriers to carrying out a larger
scale trial, and cost. We aim to recruit 100 participants
which will also allow us to estimate the likely effect size
of the intervention on a range of outcome measures.
Outcome measures
Relatives will be assessed on a range of measures at both
baseline and follow-up. All measures are conducted in a
face-to-face interview.
1) The General Health Questionnaire (GHQ-28) [12]
is a 28-item version of General Health Questionnaire
derived by factor analysis from the full 60-item ver-
sion. It is used to assess the psychological aspect of
quality of life or in the detection of psychiatric dis-
tress. Participants indicate whether their current
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recent changes in state as opposed to long-term
traits or illnesses.
2) The Family Questionnaire [13] presents partici-
pants with a range of symptoms of mental illness
that have the potential to pose a problem in family
life. It assesses the extent to which each of these
symptoms cause the relative concern and how well
the relative is able to cope with their concerns.
3) The Relationship Quality Scale [14] asks service
users and relatives to rate their perception of their
relationship with one another on scales of suppor-
tiveness and criticism. This measure has been shown
to predict outcome for people with severe depression
[14] and schizophrenia [15].
4) The Brief Illness Perception Questionnaire [16]
adapted from the original Illness Perception Ques-
tionnaire [17] measures the insight of participants
into their relative’s illness. Components include the
participant’sv i e w so nt h ec o n s e q u e n c e so ft h ei l l -
ness, comprehension of the illness, knowledge of
prognosis, the extent to which they attribute blame,
knowledge of potential causes and their own con-
cern and emotional responses to the illness.
5) The Herth Hope Index [18] consists of 12 items
designed to assess hope in adults in clinical settings.
6) The Experience of Caregiving Inventory [19] mea-
sures the experience of caring for a relative with a
serious mental illness. The 66-items are divided into
10 sub-scales, 8 negative (difficult behaviours, nega-
tive symptoms, stigma, problems with services,
effects on the family, the need to provide back-up,
dependency, loss) and 2 positive (rewarding personal
experiences, good aspects of the relationship with
the patient).
7) The Carer Well-Being and Support Questionnaire
[20] measures the experience of carers of people
with severe mental health problems. It is designed
to cover all aspects of the carer’se x p e r i e n c ei n c l u d -
ing relationships, roles, financial concerns, physical/
emotional health, stigma, worries about safety, their
satisfaction with support offered and ease of obtain-
ing information.
8) The Relatives’ Satisfaction Questionnaire (adapted
from CSQ-8 [21]) is used to assess satisfaction with
services in both arms of the trial to test the hypoth-
esis that the intervention will lead to an increased
level of satisfaction in relatives.
9) The Treatment As Usual Checklist is a short
questionnaire designed for this study to assess the
amount and type of support that participants have
received from the Early Intervention Service while in
the Treatment as Usual arm of the trial.
The Intervention
Development
During the first year of the study a CBT oriented, sup-
ported self-management package for relatives of people
with a recent onset psychosis was developed and fina-
lised. First, a systematic review of studies of psychologi-
cal interventions for relatives of people with recent
onset psychosis was conducted. This identified the key
components of effective interventions and distinguished
them from those of ineffective interventions. Second,
relatives of people who have experienced psychosis were
invited to take part in focus groups to allow in-depth
analysis of relatives’ views and experiences of a self-
management approach. The questions asked, focussed
around (i) their experiences of self-management
approaches; (ii) preferred format (or “health technol-
ogy”); (iii) what support they would like to receive; (iv)
perceived barriers. Further details on the findings of this
study are reported elsewhere [22]. Finally, participants
from the focus groups were invited to be part of an
Intervention Reference Group that was involved in an
iterative process of feedback and development to pro-
duce the supported self-management package. An inde-
pendent design company was used to style the package
professionally and an independent publisher was used to
produce the required number of intervention packs.
Features
The finalised package is modular in design, providing a
range of sections or “tools” that relatives can draw on as
needed. These modules have been designed to operate
independently of each other and contain topics such as
essential information about psychosis, ways to identify
and challenge beliefs that may cause distress, ways to
manage common difficulties faced by relatives, and cop-
ing strategies to aid recovery for both the relative and
the person with psychosis. The package is also well
referenced to guide people to existing support in related
domains such as legal advice, advocacy, charities etc.
Building on previous research in self-management for
depression, the intervention also gives relatives the
opportunity to incorporate their personal experience
into the process, to situate this intervention within a
context of previous experiences, build on existing self-
management strategies to facilitate engagement, and
highlight the self as the key agent of change [23].
The intervention has been designed to be used by rela-
tives in their own homes and at their own convenience.
As such, it has been produced as a hard copy format and
as a website and participants are able to choose to use
either or both of these formats. Both versions contain the
same information and resources. Support is provided by
an NHS support worker trained and supervised by the
research team. The support worker will offer an initial
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relative through the materials and how to use them. Fol-
lowing this, support in using the package will be offered
via email or telephone depending on the relatives’
preference.
Analysis
Quantitative data
Analysis of outcomes will be carried out using simple
descriptive statistics, tabulation and simple graphical dis-
play. Tests of statistical significance will be carried out
using Student’s t-test (quantitative outcomes) or Pearson
chi-square (binary outcomes). Further analyses to allow
for pre-randomisation (baseline) measures and to inves-
tigate the effects of missing outcomes will be carried out
using analyses of covariance or logistic regression,
respectively.
Qualitative data
Analysis will be carried out byam u l t i d i s c i p l i n a r yt e a m
of psychologists, nurses, relatives and researchers. To
ensure that the analysis is grounded in the data, rather
than reflecting pre-existing ideas, analysis will occur in
parallel with data collection so that aspects of the devel-
oping analysis can be tested in subsequent interviews.
Categorisation and thematic analysis of the data will be
developed by cycling between the analysis and tran-
scripts and periodic ‘testing’ of the analysis by discussion
amongst the entire team so as to meet accepted criteria
for trustworthiness of the analysis. In addition, we will
assess the validity of the final analysis by examining
coherence and catalytic validity, which is essentially the
utility of the analysis in identifying implications for clini-
cal practice and research that can be tested.
Discussion
The REACT toolkit has the potential to offer relatives the
information and support they need during the crucial
period of early psychosis, in a format which is highly
accessible, free to access and can be used flexibly to meet
their individual needs. It offers NHS Trusts the potential
to meet government guidelines for supporting relatives,
whilst overcoming many of the barriers associated with
training and resources in offering face-to-face family
interventions. The content of the intervention is based
on already established effective interventions, but impor-
tant questions need to be answered about whether these
interventions can be offered in a supported self-manage-
ment format. This trial will answer key questions of feasi-
bility that need to be addressed before a large scale
clinical and cost effectiveness evaluation of this approach.
Specifically, the trial will provide extensive quantitative
and qualitative data on the acceptability of the interven-
tion for relatives, exactly how they use the intervention,
and their preferences for how this should be delivered,
including format of the toolkit and type and amount of
support required to use it. Barriers and facilitators to
using the toolkit and support will be identified from the
perspective of the relatives, but also from the clinical staff
attempting to deliver REACT. Important data for future
research will include feasibility of recruitment, and reten-
tion to a large scale trial, and estimates of effect sizes on
key outcome variables which can inform future power
calculations.
This trial benefits from rigorous design in terms of
independent randomisation, blind rated assessments, and
a clearly protocolised complex intervention. In addition,
the research is conducted within a “real world” setting,
recruiting relatives from existing NHS services, delivering
the intervention alongside current treatment, and offer-
ing support via existing clinical staff. This increases the
external validity of the findings, but is also the source of
some potential limitations. These include the variation
that will undoubtedly exist in the way in which the inter-
vention is supported, and variation within the current
treatment offered as the control condition. Variation in
both is likely to be present at an operational level
between the Trusts taking part, but also for each partici-
pant, given their individual journeys through mental
health services. Extensive process measures are being col-
lected in an attempt to measure this variation with a view
to understanding potential confounds in future effective-
ness trials. Additional limitations include a follow-up
period of 6 months only, and lack of service user out-
comes. Both can be addressed in future trials but are
beyond the scope and resources of a feasibility trial.
REACT is designed to provide information and strate-
gies for relatives to build upon their existing coping
strategies. It is not designed to replace face-to-face con-
tact with Care Coordinators who provide valuable emo-
tional support and detailed specific information about
the service user that relatives are so keen to understand.
N e i t h e ri st h i sa p p r o a c hd e s igned to replace intensive
family therapy that should be offered to those families
where difficulties arising from the psychosis have caused
major breakdown in communication within the family,
or severe psychological distress for the relatives. All rela-
tives should have direct access to crisis services. Finally,
many relatives derive benefit from receiving support
from other relatives who have also experienced psycho-
sis within their family. In its current form, this toolkit
fails to offer this peer support that is available in many
Early Intervention Services via family and friends sup-
port groups. Although REACT has been designed with
user involvement to meet the needs of relatives, it is
important the toolkit is offered as part of a comprehen-
sive service for relatives.
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Page 5 of 7Figure 1 Consort diagram showing progression of participants through the trial.
Figure 2 Development of the REACT Intervention.
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